Torres-Barceló Clara, Turner Paul E, Buckling Angus
INRAE, Plant Pathology, Montfavet, F-84140, France.
Department of Ecology and Evolutionary Biology, Yale University, New Haven, USA; Program in Microbiology, Yale School of Medicine, New Haven, USA.
Curr Opin Virol. 2022 Apr;53:101201. doi: 10.1016/j.coviro.2022.101201. Epub 2022 Feb 15.
The ease with which bacteria can evolve resistance to phages is a key consideration for development of phage therapy. Here, we review recent work on the different evolutionary and ecological approaches to mitigate the problem. The approaches are broadly categorised into two areas: Minimising evolved phage resistance; and Directing phage-resistance evolution towards therapeutically beneficial outcomes.
细菌对噬菌体产生抗性的容易程度是噬菌体疗法发展的一个关键考量因素。在此,我们综述了近期关于减轻该问题的不同进化和生态方法的研究工作。这些方法大致可分为两个领域:尽量减少进化出的噬菌体抗性;以及引导噬菌体抗性进化朝着有益治疗的结果发展。
Curr Opin Virol. 2022-4
Annu Rev Virol. 2023-9-29
Viruses. 2019-11-21
Crit Rev Microbiol. 2021-8
Trends Microbiol. 2016-1-17
Curr Issues Mol Biol. 2021
Viruses. 2018-6-12
Crit Rev Microbiol. 2019-11-27
Drug Discov Today. 2021-9
Trends Microbiol. 2018-11-19
Philos Trans R Soc Lond B Biol Sci. 2025-9-4
Proc Natl Acad Sci U S A. 2025-6-3
Microbiol Spectr. 2025-7
Phage (New Rochelle). 2024-3-18
Phage (New Rochelle). 2024-3-18
Eur J Microbiol Immunol (Bp). 2025-3-17